Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Quality Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd cash flow quality index. Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow Quality Index of 0.17x as of September 2025. Operating cash flow of CN¥117.38 Million is below net income of CN¥687.04 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zhangzhou Pientzehuang Pharmaceutical Co debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Cash flow quality index of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. Historical Cash Flow Quality Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Zhangzhou Pientzehuang Pharmaceutical Co (600436) net asset quality to measure how much of total assets are equity-financed.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2001–2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd cash flow quality index by year from 2001 to 2025. Year-by-year earnings quality comparison for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600436 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥77.03 Million | CN¥2.16 Billion | ▼ -91.9% |
| 2024 | 0.44x | CN¥1.31 Billion | CN¥3.00 Billion | ▼ -43.3% |
| 2023 | 0.77x | CN¥2.21 Billion | CN¥2.85 Billion | ▼ -71.6% |
| 2022 | 2.72x | CN¥6.87 Billion | CN¥2.52 Billion | ▲ +1352.0% |
| 2021 | 0.19x | CN¥462.27 Million | CN¥2.46 Billion | ▼ -78.4% |
| 2020 | 0.87x | CN¥1.47 Billion | CN¥1.69 Billion | ▲ +237.0% |
| 2019 | -0.63x | CN¥-879.37 Million | CN¥1.39 Billion | ▼ -216.9% |
| 2018 | 0.54x | CN¥612.31 Million | CN¥1.13 Billion | ▼ -37.5% |
| 2017 | 0.87x | CN¥676.93 Million | CN¥780.43 Million | ▲ +11.4% |
| 2016 | 0.78x | CN¥394.54 Million | CN¥506.82 Million | ▲ +18.1% |
| 2015 | 0.66x | CN¥305.51 Million | CN¥463.34 Million | ▲ +9.2% |
| 2014 | 0.60x | CN¥264.50 Million | CN¥437.89 Million | ▼ -5.1% |
| 2013 | 0.64x | CN¥274.34 Million | CN¥431.10 Million | ▲ +37.4% |
| 2012 | 0.46x | CN¥162.40 Million | CN¥350.58 Million | ▼ -49.0% |
| 2011 | 0.91x | CN¥232.95 Million | CN¥256.54 Million | ▼ -13.9% |
| 2010 | 1.06x | CN¥205.41 Million | CN¥194.70 Million | ▲ +6.1% |
| 2009 | 0.99x | CN¥129.52 Million | CN¥130.25 Million | ▲ +1020.4% |
| 2008 | 0.09x | CN¥12.57 Million | CN¥141.67 Million | ▼ -85.7% |
| 2007 | 0.62x | CN¥60.04 Million | CN¥96.40 Million | ▲ +2.9% |
| 2006 | 0.61x | CN¥50.70 Million | CN¥83.81 Million | ▼ -23.6% |
| 2005 | 0.79x | CN¥69.06 Million | CN¥87.18 Million | ▼ -66.4% |
| 2004 | 2.36x | CN¥98.67 Million | CN¥41.90 Million | ▲ +340.9% |
| 2003 | 0.53x | CN¥32.36 Million | CN¥60.57 Million | ▼ -70.2% |
| 2002 | 1.79x | CN¥105.45 Million | CN¥58.79 Million | ▲ +42.1% |
| 2001 | 1.26x | CN¥65.84 Million | CN¥52.16 Million | — |